Modifications should be created cautiously along with the frequency of blood glucose monitoring should be increased. Changes in concomitant oral antidiabetic treatment may be required.Short SAFETY Assertion: Failure to utilize the Dexcom Ongoing Glucose Monitoring Program and its components according to the instructions to be used delivered togeth